Peer Review History
| Original SubmissionJune 5, 2021 |
|---|
|
PONE-D-21-18582 Copy-out-paste-in transposition of a Tn6283-like integrative element assists interspecies antimicrobial resistance gene transfer from Vibrio alfacsensis PLOS ONE Dear Dr. Nonaka, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. I have added some comments to help guide in this revision below. Please submit your revised manuscript by 22-9-2021. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Ruth Hall, PhD Academic Editor PLOS ONE Additional Editor Comments: Your manuscript incudes some interesting findings but both reviewers had difficulty following the text and had some concerns about particularly the naming you have used. They have given some quite detailed suggestions all of which look very helpful. I agree with the reviewers on most points particularly that the text is very hard to follow because the information needed (e.g. sizes of PCR products, predicted sizes of restriction fragments, exactly how PCRs were performed) is not provided. I have a few comments to reinforce or add. 1. Please do not use Tn with a number for an IE. The reviewers have explained why. 2. Please do not use “copy-out paste-in”, which is a specific transposition route and not applicable to integration. It’s known that some tyrosine recombinases perform only one strand exchange. Replication is then needed. This route could give the outputs you observe. The first Int system of this type was IntI1 the integron integrase and this was discovered about it in the 1990s. Please consider this. 3. Please reduce the use of transposon references and information and replace it with Integrase or IE stories. 4. Conjugation frequencies must be expressed as per donor. Please fix this. I will accept scatter plots. 5. A strain Table is needed. 6. I was surprised that 2 genes should be called Int as they has such different sizes. So, I checked them using BLAST and found that IntA has the required domain but IntB has no known domains. To see domains, once the search is complete click on the graphic summary and look right at the top. Hence, I insist that this orf be annotated as an orf. 6. I also noticed that in the database entry for pSEA2, intA is not annotated as such. Please fix this. 6. IE encoding the same or closely related Int should integrate at the same position. Is your IE in the same gene in Vibrio and E. coli? More on this is needed. 6. The searches I did revealed that there are several IE of this type in Vibrio species. Are they in the same location? Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. PLOS ONE now requires that authors provide the original uncropped and unadjusted images underlying all blot or gel results reported in a submission’s figures or Supporting Information files. This policy and the journal’s other requirements for blot/gel reporting and figure preparation are described in detail at https://journals.plos.org/plosone/s/figures#loc-blot-and-gel-reporting-requirements and https://journals.plos.org/plosone/s/figures#loc-preparing-figures-from-image-files. When you submit your revised manuscript, please ensure that your figures adhere fully to these guidelines and provide the original underlying images for all blot or gel data reported in your submission. See the following link for instructions on providing the original image data: https://journals.plos.org/plosone/s/figures#loc-original-images-for-blots-and-gels. In your cover letter, please note whether your blot/gel image data are in Supporting Information or posted at a public data repository, provide the repository URL if relevant, and provide specific details as to which raw blot/gel images, if any, are not available. Email us at plosone@plos.org if you have any questions. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: I Don't Know Reviewer #2: N/A ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This manuscript describes basic characterisation a non-conjugative integrative element (named “Tn6945”), carrying a beta-lactamase (bla) gene, on the chromosome and a plasmid of a Vibrio ponticus isolate from an aquaculture site in Japan. The element was identified following conjugation with E. coli, when either it or the whole plasmid was transferred to the chromosome, the latter process identified as being dependent on recA. “Tn6945” is related to “Tn6238” previously identified by the same group on a related plasmid in a different Vibrio species. The manuscript seems to imply that “Tn6945” is only the second example of this element to be identified (it would be helpful to make this more explicit if this is the case), in which case describing it would be useful. The approach/results appear technically sound, but it is a bit difficult to tell from the descriptions provided, and the conclusions generally justified, but naming these elements transposons is problematic (see point 1 below). Also, the manuscript requires some reorganization rewriting and condensing, as it not easy to follow and is quite wordy and repetitive in places (see examples below). 1) “Non-conjugative integrative element” vs transposon Description of “Tn6945”/”Tn6238” elements as a transposons is at best confusing, when they carry tyrosine recombinases rather than true transposases. Inconsistencies/contradictions in the text suggest that the authors are not really sure how to describe them either e.g., “nonconjugative integrative element Tn6283” (line 62), “a new type of transposon” (line 66), “Tn6283-like integrative elements” (line 69), “active integrative element” (lines 115-6) and their is reference to them having both IR (typical if transsponsons) and att sites (typical of integrative elements). While some ICE were historically given Tn numbers it is not helpful to perpetuate such confusion and the nomenclature of these “Tn6945”/”Tn6238” elements needs to be carefully considered and if these are a novel type of element then this needs to be clearer. 2) Lines 111-131 – descriptions of insertions This section needs to be written more clearly/reorganised/condensed. Line 111 – this is called “MULTISPECIES: class A beta-lactamase” by NCBI RefSeq. It might be useful to obtain a name for it from NCBI, – “a 7.1 kb repeat region”. Line 114 – it might be better to avoid “homology” here? Gene product identity would be higher than coding sequence identity, so this might be written the other way round. Lines 115-116 – the evidence for this is from the conjugation experiments? This is not clear. Lines 120-121 – what is the evidence for targeting, as opposed to random insertion? Lines 122-4 – “Tn6945” inserts itself, rather than its IR? It’s not clear whether it is being proposed that “Tn6945” has IR, like a typical e.g., Tn3 family transposon (and why are the repeats called C and C’?) which are internal to such Tn, or it has an att site that recombines with target att site to create hybrid sites, as for integrative elements. att site are mentioned in the Fig. 1 legend but are not discussed until later in the text, which is also a problem. 3) Other scientific points Lines 63, 85, 88, 354, 359 - why was 42 deg C used? This needs to be explained. Lines 81 - it might be useful to make it clear when citation are to previous papers from the same group of researchers (i.e., use “We”). Lines 106, 380-1 – is this version of PacBio alone sufficient to give accurate sequences? Line 109 – is the accession no. for this given anywhere? Lines 179-80 – att need explaining before this point in the manuscript Line 223 – what concentration of ampicillin? Line 240 – V. cholerae is not always from sea food? Line 250 – the term “super-integron” should not be used. Use e.g., “sedentary chromomsomal integron” instead. Line 264-66 – is “Tn6945” the smallest of only two of this type of elements to have been identified to date? Or are there other examples in addition to Tn6283? This needs to be clear, i.e., state in the Introduction that is a new type of element, if this is the case. Lines 266-70 – is it possible to tell anything about how the bla gene might have ended up in this location? Is there really evidence for an “ancient origin”? Lines 275-6 – these genes need to be described in Results. Lines 278-80 – what is the evidence of this for the “latter” i.e., Tn6283? This is not really clear from the Results and both references are about IS. Lines 292-307 – a table explaining the different strains, with some additional details in the text in the case of more complex constructions, might be clearer. The first sentence should be deleted and the citations included in other places. Line 347-59 – as some strains used are transconjugants, it might be more logical to describe conjugation experiments earlier in Methods? Line 355 is ambiguous and needs to be written more clearly. Lines 364-8 – digestion should be described before hybridisation and something like “using the 5'end of intIA, amplified using primers LN112 and LN113 (Table 1) and the PCR DIG… as probe” would be simpler. 4) Minor/formatting/wording/English etc Some streamlining/reducing repetition in different sections etc. is needed, as well as some reorganization. Some examples are given below. Line 61 – “The” is not needed here. Lines 63-4 – suggest “…, following conjugation it could integrate into the chromosome by…” Line 71 – “in this study we mated” Lines 84-91 are unclear and need rewording. Lines 110 etc – change “beta” to beta symbol Lines 118, 120 etc – suggest present tense for facts that are still true i.e., “contains”. “indicates” etc. Line 125 – “the previously reported plasmid” can be deleted. Line 127 – can delete “that of”. Line 128 – could be condensed to “…from Southern hybridization (19)” Lines 129-30 – suggest “carries Tn6945 in the same place as in…” Line 134 – “pSEA2” would be clearer than “the plasmid” here. Also line 143 – “integration of pSEA2” Line 136 – “homology” is not really the best term here, if they are identical? Line 142 – suggest “movement of Tn6945 to new locations” Line 184 – meaning actually “chromosomal copy of Tn6945 in V. alfacsensis is functional”? Line 198 – suggest “two sequences” rather than “sequence types” Line 199 – “absence of pSEA-2 from” Line 206 – “a” of attB needs to be italicised Lines214-5 – ambiguous and needs rewording, “respective” is probably not needed (nor line 219) Line 225 – “was highest” Line 229 – better to say something like increased copy number resulted in increased resistance? Line 247 – suggest “other conjugative”, might be more logical to mention islands after all of the plasmids? Lines 347-8 – giving the strain names here is not really necessary. Lines 393 – this information might be more easily accessible if presented in a supplementary table, with the most relevant accessions quoted in the text. References – several references are missing page nos. (e.g., Refs 5, 8, 15, but all need checking) and Title Case (i.e., First Letter of Each Word In Upper Case Like This) should be removed ((e.g., Refs 6, 8). 5) Figs. These could be improved/simplified/split into smaller figures, considering how they would look on a journal page and if they relate to different parts of text. Fig. 1 - I don’t think that part A is necessary – the information in it is clear from the text. If retained then the brackets need to be explained. Part B(i) is not clear (e.g., the legend does not explain what “CAIM” is and inverting the orientation of pSEA2 would make the comparison clearer) and is probably not needed. I would suggest putting Part C first, then B(ii), with a line underneath showing pSEA2 and then part D. Fig. 2 could be supplementary. It is not clear what “divided by the donor CFU and recipient CFU” in the legend and “Log(transconjugant/(donor/*recipient)” on the Y axis mean? Fig. 3B and C could be supplementary. In Part A the Chr2, pSEA and pYa249 diagrams are not really needed and maybe the remainder could be combined with Fig. 1C, B(ii) and D? Supplementary Information The order of Figs S1 ad S3 seems to have been switched vs. the legends. It would be helpful for review if the legends were on the same page as each figure. Reviewer #2: The manuscript describes the identification of an interesting integrative element containing a bla gene from marine Vibrio. It is detected in chromosomal and plasmid sites and it's transfer and integration into E. coli is demonstrated. These are notable findings. Unfortunately, as noted below, I feel there are a significant number of issues that need attention. Lines 1 (manuscript title), 133, 135, 164 ,166 and 203 (and possibly elsewhere): To avoid confusion, it would be preferable for movement (translocation) of Tn6945 NOT be described as "transposition"; it is site-specific integration, and it doesn't involve a transposase. Line 75: "‥.embedded on the plasmid‥." should be "‥.embedded In the ELEMENT‥.". Line 87: Selection said to include tetracycline and ampicillin, yet next sentence states transfer frequency for tetracycline only. How can this be? Line 95, Fig 1Bi legend: More description is required - why is CAIM 1831 segment shown? Doesn't actually show "insertion sites", rather comparative locations of Tn6945. This figure doesn't seem to provide any useful information beyond what should be in the text (see below) and hence should be removed. Line 109: S1 Fig is cited but the legend for S1 is incorrect. The provided S3 legend corresponds to the figure I think. That legend needs to provide the definition for Crick/Watson strands used here since various exist. Is there a meaningful reason why Chr1 of 04Ya108 is shown inverted with respect to Chr 1 of the other strains? If not, it should be reverse complemented for consistency. Line 112: Rewrite sentence to include that the segment is absent from the corresponding region of CAIM 1831. Line 114: Indicative values should be provided for "very low gene product identity". Line 115-117: It is not clear to me what data specifically has "confirmed" that the repeated region is an active integrative element. The evidence for this assertion needs to be stated succinctly. Moreover, if this is the case I find it perplexing that it has been given a Tn number since it is clearly not a transposon. I appreciate that historically some integrative elements were assigned Tn numbers, but the important distinction between IE and Tn (site-specific recombinase verses comparatively random transposase) has been understood for some time. The practice of assigning Tn numbers to IEs promotes confusion and is hence unhelpful; it should not be continuing in 2021 - alternative naming conventions are being used for IEs. A complicating issue here is that at this time it is unclear what type of IE this one represents. It does not appear to be an ICE, but it could be an IME (integrase-like proteins have been found to serve as a relaxase in some conjugative plasmids) or it could be a form of a CIME. In any case, a name that is not misleading would be preferable. Line 121-124: This section describes insertion sites in E. coli, shown in Fig 1D, but the insertion sites from the Vibrio strains (shown immediately above them in the same figure) are ignored in the text. If they are not informative they should be removed; but surely they are. Is the information consistent between the organisms? I would have thought a consensus motif for attB target sites might be worth deducing/showing? Line 125: Indicative values should be provided for "very similar". Line 128: "previously" should be "previous". Line 130-131: Without first meaningfully describing the similarity relationship between pSEA1 and pSEA2, it is difficult to know whether deducing a precursor based on the presence/absence of a site-specific integrative element is appropriate. Section starting line 133: This section starts by outlining a plausible scenario for plasmid integration via a two-step process involving homologous recombination. However, analogous mobile element flanked plasmid co-integrate arrangements can also arise in a single step in the absence of homologous recombination. The possibility of this (and possibly other) scenarios needs to be noted here also so the rationale for the subsequent experiments is clear to a reader. The subsequent two paragraphs, and Fig 2, which describe the data, are very difficult to understand in terms of what was done and the data resulting. It all needs to be described much more clearly. Plasmid integration is said to be based on transfer of both ampicillin and tetracycline, but then only tetracycline-resistant transconjugants are described, and only Tet + Ap is shown in Fig 2. Elsewhere in the paper, transfer frequency is provided "per donor" as is established practice. Frequencies indicated in Fig 2 should do likewise, rather than per donor x recipient. Moreover, I think it would be preferable for this data to be provided in a table rather than a graph, so it is clear what data was obtained for each mating. For example, the single dot for Tet+Ap transfer in the delta-recA strain does not really agree with what is stated in the text. What is the explanation for the apparently reduced Ap transfer in the delta-recA strain? Could this be responsible for the failure to detect any Ap + Tet transfer (i.e., insufficient sensitivity)? If so, the data doesn't really provide clear support for the proposed two-step scenario. Section starting line 168 (to 191) and manuscript title: Copy-out-paste-in has been employed to denote a mechanism of transposition. The mechanism employed by this type of integrative element may indeed share some commonalities (which are certainly worth noting), but the enzymes involved and the biochemistry among other things are going to be different (e.g., the observed strand bias, as noted in the Discussion). I therefore feel that simply using the same Copy-out-paste-in term to describe this integration mechanism will again lead to confusion, leaving some readers with the impression that transposition and integration are the same when they are clearly not. Additionally, mechanisms used by other integrative elements are not explained anywhere in the manuscript. Are they different? Does the data here preclude them? The failure to detect an empty attB site by PCR of itself does not represent compelling evidence that a copy of the element is retained in the donor replicon. Maybe the empty site is not re-joined and is hence lost from the population. Was a positive control performed to show that an attB site could be detected for a different element that is known to generate them? Indeed, could the attB PCR detect the empty site of CAIM 1831? Without additional evidence, it is premature to conclude that a copy-out-like mechanism is used. Line 215: Why is Tn6283 mentioned here? It doesn't seem to encode resistance so how is it relevant to these studies? Line 228: Although the results are mostly consistent with a correlation between Tn6945 copy number an Ap MIC, it is an overstatement to say they "clearly" show copy number affects resistance level; there is only a single strain with three copies, some strains with one or two copies exhibit low resistance, while another with one copy exhibits as much resistance as the most resistant isolates with two copies. This suggests that there are other factors at play so the data should be interpreted conservatively. Fig 4 legend: What do the different colours denote? Discussion line 256: The conviction in the two step mechanism is not justified by data presented. Other alternatives, and known mechanisms of other integrative elements should be elaborated. Discussion line 275: The possibility that this element might be mobilisable (i.e., an IME) should be canvassed, particularly given the multiple genes of unknown function. However, all that might be needed is an oriT site. Has a candidate oriT sequence been identified in pSEA1/pSEA2 (likely near their relaxase gene), and is there a similar sequence in Tn6945? Line 573: The legend shown is presumably for S3 rather than S1. In any case, I doubt enough information is provided for a reader to understand the figure. Line 581 and S2 legend: "‥.arch‥." should be "‥.arc‥.". I could not find the significance of the "contig 1" described anywhere so it should be removed (from here and the figure). What is the meaning of the gene colours used in B? Fig S2A: Are putative conjugation or replication initiation genes evident in the pSEA2 sequence? If so, it would be informative if these additional genes at least could be indicated on the figure. Fig S2B: pSEA1 should be included in the figure label. The legend provided is inadequate - what do the gene colours mean? The figure shows locations of the elements, not "insertion positions", and for both plasmids, not just pSEA1. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-21-18582R1Atypical integrative element with strand-biased circularization activity assists interspecies antimicrobial resistance gene transfer from Vibrio alfacsensis PLOS ONE Dear Dr. Nonaka, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. I would like to sincerely apologise for the delay you have incurred with your submission. Your manuscript has been reviewed by the two previous reviewers; their comments are available below. The reviewers have indicated that although the revised version has improved respect the original version, there are still significant concerns that need to be addressed. Please revise the manuscript to address all the reviewer's comments in a point-by-point response in order to ensure it is meeting the journal's publication criteria. Please note that the revised manuscript will need to undergo further review, we thus cannot at this point anticipate the outcome of the evaluation process. Please submit your revised manuscript by Apr 14 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Miquel Vall-llosera Camps Senior Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: (No Response) Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: I Don't Know Reviewer #2: N/A ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This revised manuscript includes interesting and important information about a new type of integrative element, and the scientific aspects have been improved by adding/clarifying experimental details. However, further revision is still needed to address some scientific points and better present the data and conclusions, as the manuscript is still hard to follow - information needs to be presented in a more logical order - and the text is still wordy and repetitive and could be condensed in places. I have tried to give some more detailed suggestions of how this could be done in the comments below. 1) Nomenclature for the new integrative elements (Response) In the revised manuscript, we have explicitly stated that the unclassifiable integrative elements, identified in this study, are a new class of mobile elements. Therefore, we have used an “SE-“ prefix (strand-biased circularizing integrative element) to refer to these IEs in the revised manuscript. We believe that using numbers to identify these DNA elements would make it easy to handle (refer to) them in existing and future mobile DNA databases. Therefore, we have used numbers to refer to the SEs in this manuscript. NEW COMMENT: “SE” is not a particularly descriptive name. Including at least “I” for “integrative” should be be considered (i.e., “SIE”?). Also, it might be better to introduce this term only after describing identification of the strand biased mechanism. The Results sections could be reorganised to first describe the experiments that led to this conclusion (i.e., move lines 278-367 to after lines 168 and maybe combine lines 169-79 with it, ending with lines 129-131. Also consider the best order for Results sections on lines 181-276 and369-415- e.g., combining the sections on target preference for SE-6945 and SE-6383, or at least placing them together? In the Abstract, the name SE-6945 is used on line 28, before the term SE is explained on lines 34-5. The explanation should be placed earlier, first stating something like “This 7.kb element has four coding sequences, which are related to those of an element previously referred to as Tn6283, two of which… PCR and sequencing revealed these elements generate a copy of only one strand…, so they are collectively termed SE (…) here.” Also, the name SE-6283 is used on lines 80, before the term SE is explained on lines 93-5 – again suggest “called Tn6283”, but delete “(renamed…)” here and use Tn6283 for the rest of the paragraph, and “a related element” on line 91, then ex[plain the term. Another part of the response states “We prefer to use 4-digit numbers to keep this compatible with the existing Tn database, and in part considering the ease of handling them in future databases” but on line 205 the names “SE-VhaWXL538” is used , from the strain ID. Is the idea that this would be numbered at some point and if so, would the Tn registry be responsible for assigning the numbers? (also lines 502-3). 2) Introduction, lines 96-107, Use of transposition, integration insertion etc, L The authors have explained why they prefer to use transposition as a more general term but I think that it would be better to incorporate these definitions with lines 53-72 and end the Introduction with the statement about identification of a new integrative element. Lines 104-7 (translocation) can simply be removed, as they are not relevant. I also think the use of the terms “integration” and “insertion” might be better reversed, to follow the traditional definition of integration, if SE are being called integrative elements. To me, SE-6945 integrates in the traditional sense, but the plasmid “insertion” is more complex, as it requires an additional recombination step. 3) Results, lines 110-180 NEW COMMENT: The title of this section could be reconsidered, as it also discusses “Tn6283” and other points and the section needs to be reorganized and condensed. Results of sequencing 04Ya240 could be moved up and if the sequencing of TJ249 helped identify SE-6945 then this information should be before the descriptions of the proteins. The proposed gene product names are used on lines 127-8, but not explained until lines 132-4 – they should be explained first and then used. PREVIOUS COMMENT: 5. Lines 115-116 – the evidence for this is from the conjugation experiments? (Response) We used the term “active” based on the evidence for (i) the circular form generation in the absence of pSEA2 in V. alfacsensis (new Fig 4, previous Fig 3) and plasmid-free E. coli (new S6 Fig) and (ii) new junction generation (attL, attR) in E. coli during conjugation experiments. We rephrased this sentence to explicitly state this fact as “This 7.1-kb region was confirmed to be active in generating its circular copy of top strand in E. coli and V. alfacsenis and inserting it into new target locations in E. coli in this study” in lines 129-131. NEW COMMENT: As referred to above, I think that this information is in the wrong place. The point about the element being active and the top strand being involved should be after the description of the experiments that identified this (“to be active in generating its circular copy of top strand” also needs rewording). Lines 164-7 are very unclear. The information about the mph(A) cat region is confusing. What kind of repeat? A repeated mobile element? Direct repeats/TSD? I couldn’t access the Figshare directly from the link in Ref 72/Table S2 (please check this) but I did manage to find the sequences. Contig names seem to be the other way round, i.e. contig2 is 14.2 kb. It looks like pSEA2 was transferred to E. coli and inserted, but a composite-transposon like structure was lost as a circular molecule? This all needs to be written so that it is much easier to follow and so that it does not get in the way of the main point about the two insertions in the chromosome. Line 122 – the gene name would be blaCARB-19, with bla in italics and CARB-19 as subscript, but the protein is not the same as CARB-19 in the NCBI reference gene catalog. As NCBI now assigns bla protein names/numbers it would be better to use their nomenclature, obtaining a name/number from NCBI if possible. PREVIOUS COMMENT 7. Lines 122-4 – “Tn6945” inserts itself, rather than its IR? It’s not clear whether it is being proposed that “Tn6945” has IR, like a typical e.g., Tn3 family transposon (and why are the repeats called C and C’?) which are internal to such Tn, or it has an att site that recombines with target att site to create hybrid sites, as for integrative elements. att site are mentioned in the Fig. 1 legend but are not discussed until later in the text, which is also a problem. (Response). We understand the reviewer’s concern. We changed the phrase to “SE-6945 inserts itself ending with 5’-GTA-3 (Fig 1 A) along with an additional 6 bp next to the 5’ end of C at attL on the donor molecule into the target site” (line 177-178). C and C’ are from core site of site-specific recombination mediated by tyrosine recombinase (i.e. Lambda Int). The problem with this new integrative element is that we cannot deduce how much longer does the cis-element involved in recombination extend from motif C/C’. Therefore, we simply defined the term attL and attR as “The border regions between SE-6945 and its target locations” and then stated “The border regions between SE-6945 and its target locations were termed attL (intA-proximal side) and attR (intA-distal side) (Fig 2 A)” in the revised manuscript (line 169-170). We also elaborated to explain the feature around nicking sites at attL and attR at lines 170-176 and lines 210-216. NEW COMMENT on lines 169-179 - see comments above on moving this section. Line 141 – please explain in the text why the names C and C’ are used. Also please consider whether just referring to border regions, rather than att, until the ends of the element have been properly defined would be better. 4) Other scientific points Line 61 – it is the attC site only that is folded Line 164 etc -is insJ associated with a known/named IS? If so, it would be better to use the IS name. Line 239 – it would be helpful to note here that Ap resistance is on SE-6945, Tc resistance on the plasmid. Line 255 – the “homology stretches” are actually identical? Lines 287, 489 – do these descriptions apply to all IS? If not, “some IS” should be used. Lines 288-9, 469– please reconsider descriptions relating to integron (upper case I not needed) gene cassettes and “empty donor sites”. The attC site belonging to a particular cassette moves with that cassette. Excision may create an empty attI if it was the only cassette, otherwise the downstream cassette moves up the array. Also, Ref. 40 on line 469 dates from before the single stranded mechanism was identified. 5) Table 1 This is useful but can be simplified and condensed. The Vibrio isolates need to be listed before the transconjugants and would also probably be better before the E. coli, with LN95 under 04Ya249. A heading “transconjugants” could be added, grouping these to reduce the size of the table, i.e., put LN# numbers for all isolates with identical characteristics on a single row (or even just list the number of transconjugants of each type, if LN numbers are not referred to elsewhere in the manuscript). This would allow footnote c to be simplified e.g., note the selection used in the table itself and the text already states in several places that selections were done at 42 deg. Footnote b is hard to understand. Please also align text in the first column on the left and at the top of each row, to make it easier to read. W0452deltarecA should be JW0452deltarecA? Are all resistance genes are on the plasmid in each case? This should be made clear. Lines 531-3, 565-7 could also be incorporated into Table 1. 6) Figures Fig. 1A– the arrowheads might be better left off, as the reasons for proposing these nicking sites have not been introduced at this point in the text and showing them on a sequence is clearer /more informative. I would also suggest placing part C first to better follow the order in the text. Fig. 2 – see suggestions on reorganisation of text. As the two strains at the bottom of Part A don’t appear to have been used in Part B maybe these diagrams could be moved to Supplementary? Legend - line 220 “coordinates”. Line 221 “sequences were” “unpredictable” is the wrong word here – suggest “the bases in the putative crossover region could not be defined and are shown as X”. “one site on the left side on the top strand” is unclear and needs rewording. Fig. 3 – line 270 – “no transconjugants were”. Fig.4 - Legend – line 310 “Design of” can be deleted. Primer names are very long – can PCR reaction numbers be put in primer table? Line 215 – suggest “as shown as separate lines, with SE in orange”. “IS3 route”, “ICE/IME route” “gene cassette route” shown on the figure are not referred to in the legend. Reduce overlap between description of parts A and B. Line 329 – “as arrowheads”. Lines 372-8 – legends should generally not contain methods. Fig. 5 – mention Ap in the title and add “Ap” before MIC on vertical axis label. Fig. 6 - line 420 – “and carry” 7) Supplementary Fig. S1 legend, line 870 “and TJ249” Fig. S2 legend, line 885 – “genes were”, line 887 “PacBio assembly” Fig. S3 legend – reword “part of the mobile DNA unit of the SE element” (also Fig. S4 lines 902-3, Fig. S7 line 930). Fig. S6 legend – suggest “(B) Relative copy number of attS in V. alfansensis LN95 (no pSEA2)” Relative to what? 8) Minor/formatting/English The Methods section could be simplified/condensed by restricting information to what was done, rather than too much description of why, especially if already explained in Results. Some minor rewording for accuracy/clarity is also needed to make the manuscript easier to read (some suggestions are included below). PREVIOUS COMMENT: 14. Line 240 – V. cholerae is not always from sea food? (Response) V. cholerae is indeed not always from sea foods as described in the cited reviews. These descriptions are correct. Thus we did not make changes to the revised manuscript. NEW COMMENT: now line 430. I don’t understand this response. If these Vibrios are not always from sea food then the wording should be changed. PREVIOUS COMMENT: 36. Line 184 – meaning actually “chromosomal copy of Tn6945 in V. alfacsensis is functional”? (Response) Because only one SE-6945 copy is present in LN95, detection of circular SE-6945 in LN95 indicates that the cis-elements (attL/attR) and strand exchange enzymes encoded in the chromosomal SE-6945 is indeed functional, while those of SE-6945 on pSEA2 is obviously functional as its transposition was observed in E. coli. We explicitly stated that “This suggests that the cis-elements (attL/attR) and strand exchange enzymes encoded by the chromosomal copy of SE-6945 are also functional in V. alfacsensis” in lines 304-306 in the revised manuscript. NEW COMMENT: This was a comment on wording only. I think that what I previously suggested is clearer PREVIOUS COMMENT: 38. Line 199 – “absence of pSEA-2 from” NEW COMMENT: Sorry, this should have referred to line 299, now line 515, and is simply a wording issue. If pSEA2 is absent then it is not “in” LN95, so “from” is clearer/more correct. OTHER NEW COMMENTS: Lines 37-8 – could delete “in addition to conjugative plasmids” Line 61 - “of an integron cassette” or “of integron gene cassettes” and “the phage CTX“. Line 33 – “The copy number and location” Line 64 – “a Y-transposase”, “an S transposase. Line 67 – please give full names for these elements in addition to abbreviations. Line 92 – “the E. coli chromosome” Line 99 – “as” before transposition should be omitted. Line 114 – “and transconjugants selected on erythromycin” Line 120 – please give the accession no. for the CAIM 1831 sequence here or in Fig. S1. Line 121 – “plasmid” is not needed before pSEA2. Line 122 – “a 7.1 kb repeat region”, not “the 7.1 kb repeat region” Line 133 – suggest “predicted” rather than “estimated”. Lines 159-60 – maybe “also carries two copies of SE-6945, in the same locations on the chromosome and plasmid as in 04Ya249”? Line 186 – “transconjugants were screened on Tc alone, …” Line 195 - “other transconjugants” Line 198 – delete “the” Line 201 – “searched for” Line 214 - “integrons”. Lines 234-5 – “altogether in a recA-null” Lines 243 – this needs rewording - transconjugants are not transferred Line 246 – “in any of the four” Line 248 – suggest “the transfer frequency of Ap resistance to JW0452deltarecArif was about 17 fold lower than transfer to JW0452rif”. Was this for the means? Line 253 - “in mean” needs rewording. Line 256 – “integration into the recipient chromosome” Line 281 – fix “E. col” Lines 282-3 – could this be expressed the other way round? i.e., tyrosine recombinase typically produce staggered cuts at att sites? Lines 288, 291, 360 etc – “single stranded”, “double stranded” Line 297 – “anneals inside the integrative element and the other outside it” Line 301 – “primer sets”. Line 308 – “long PCR conditions were used” Line 372 – “their genome” Lines 379-80, 387- need rewording - only Ap MICs were obtained. Line 388 – “MICs against individual strains are”. Not clear what “when focused on a class of MIC 500” means. Line 405 – “screened for”, or “identified” Line 406 – “and related SEs” Line 431 – “linking” not really the right word here, “aiding movement between”? Line 462 - “transposon mechanisms”? Line 469 – needs rewording Line 473 - “unjoined”? Line 475 – “a process equivalent to” Line 496 – “relaxases”, “and oriT in SE-6945 or SE-6282” Lines 567-8 would be better incorporated into lines 563-5 i.e. add “and incubated at 42deg C to supress growth of Vibrio strains” to the end of the sentence. See also comments above on incorporating information into Table 1. References – species names should be in italics. Reviewer #2: The revision of the manuscript has clarified many aspects of the original version. I don't think it will be productive to argue the utility of general verses specific use of the words transposon/transposition. More importantly, I feel that the use of "SE" in place of "Tn" is a satisfactory solution that clearly implies distinctions between these particular integrative elements from others, and Tn-named elements. Further suggestions: Line 25: "multidrug resistance conjugative plasmid" is probably better written as "conjugative multidrug resistance plasmid". Line 31: "of its one specific" can just be "of one specific". Line 33: "Copy numbers and location" should be "The copy number and location". Line 48: Sentence should be: Conjugative plasmids and integrative and conjugative elements (ICE) [6] are DNA units that can move from one cell to another through conjugation machinery that they encode. Line 100: Just a suggestion. Replicon fusion between plasmids and/or chromosome could be termed "cointegration", leaving "integration" to be used for site-specific recombination, since "insertion" is commonly used for events not involving site-specific recombination. Line 103: I appreciate the authors explaining why they haven't used the term "translocation". However, since it is not used the explanation isn't needed in the paper - it might appear perplexing to a reader. Line 114: "and the transconjugant was first selected" should be "and transconjugants were selected". Line 166 and Fig S2: The significance of contig 1 is not clear to me. How does it indicate movement of SE-6945? Line 186: "transconjugant was" should be "transconjugants were". Line 190: " generated intA-containing fragments originating from" should be "possessed intA-containing fragments located at". Line 197: It is more correct to say that pSEA2 integration relies on SE-6945 transposition, since generally transposition of SE-6945 will NOT result in plasmid integration (it will do so only rarely). Line 212 and elsewhere: "Sequence logos" should be "Sequence logo". Line 257: "The Tn3-like" should be "Tn3-like". Line 347 and 353: (Fig 4E) should be (Fig 4D). Line 371: "in genomes" should be "in their genomes". Line 372: Why/how would/could SE-6283 be expected to influence beta lactam resistance? Seems like a complete red herring to me. Line 388-391 paragraph: Could just be: The MIC of individual strains is shown in Table S1. There was a trend for strains with SE-6945 insertion into insJ to show a higher MIC than strains with insertion into yjjNt. Thus, the location of SEs can result in phenotype variation, possibly due to the differences in the expression levels of their cargo genes. Line 414: As written, the sentence implies the opposite of what is meant. I suggest change to "and, like attB of SE-6945 did not possess an inverted repeat structure." Line 418: Isn't it five genomic locations shown in Fig 6A? Line 462: "movements" instead of "moves" Line 471: "possibly the CDS2" rather than "i.e., CDS2". Line 473: " transposases" instead of "transposase". Line 497: It might be worth mentioning here that a tyrosine recombinase-like protein has been shown to function as a conjugative relaxase, particularly since these elements contain two such proteins. See reference https://doi.org/10.1111/mmi.13270. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
PONE-D-21-18582R2Atypical integrative element with strand-biased circularization activity assists interspecies antimicrobial resistance gene transfer from Vibrio alfacsensisPLOS ONE Dear Dr. Nonaka, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please consider the comments of the reviewers to improve the manuscript. Please submit your revised manuscript by Aug 01 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Axel Cloeckaert Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: (No Response) Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: I Don't Know Reviewer #2: N/A ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This revised manuscript is improved, and I have not commented further on the organisation, as the authors have provided reasons why they do not want to change this. The manuscript is essentially now acceptable for publication, but as PLoS One does not copyedit accepted manuscripts, addressing the few small points below, which include suggestions to further improve English/wording, would enhance clarity/readability. 1) ORIGINAL COMMENT: 71. Lines 243 – this needs rewording - transconjugants are not transferred. (Response) We want to emphasize the fact that transconjugants were obtained, albeit at a low frequency. Thus, the statement remains the same in the revised manuscript (line 266). We confirmed that these colonies received resistance genes and not spontaneous mutants by conducting single colony isolation and PCR. NEW COMMENT: Sorry if this was not clear – it was simply a comment on the wording – “the transfer of Tc Ap-resistant transconjugants” does not make sense - transconjugants are not transferred, they are the result of transfer. It could be changed to e.g., “transfer of both Ap and Tc resistance”. 2) ORIGINAL COMMENT 77. Lines 282-3 – could this be expressed the other way round? i.e., tyrosine recombinase typically produce staggered cuts at att sites? (Response) Staggered cuts indicate occurrence of a double-strand break, and are misleading (the product is different from the staggered cuts made by restriction enzyme). Therefore, wedid not change the phrase (line 308-309). NEW COMMENT: Lines 308-9 - “this assertion is based on the notion that tyrosine recombinases have a nature to not produce blunt ends at att sites on double stranded DNA during strand exchange”. This wording is quite convoluted – would e.g. “recombinases generally do not produce blunt ends” work? 3) Minor wording suggestions Lines 34-5 – “of integron gene cassettes” Lines 76-7, 83-4 – abbreviation AMR could be explained on lines 76-7. Line 89 – “elements” Line 96 – suggest delete “the currently unclassifiable integrative element” Line 99 – “movement” Line 100 – “the terms” Line 106 – “is called” Lines 121-3 – “VHH-1”, “GMA” and “GMA-1” should not be in italics. Line 130 – “insJ” Lines 132-5 – need rewording for clarity, delete “member of” Line 136 – “in the aligned region” Lines 151-3 suggest “SE-6283 and SE-6945 carry imperfect 19 bp inverted repeat motifs at their ends, (Fig 1 B), termed C and C’ based apparent on functional equivalence to the core-type sites of phages” (assuming “Fig. 1 fB is not correct here?). Line 169 – “the two E. coli chromosomal locations and the two locations” Line 182 – “a specific location in the” Line 185 – “The SE-6945 integration” Line 187, 194 – “selection with Ap alone” Line 188 – “transconjuants, 12 had integrase” Line 199 – “the NCBI” Line 201- “contains” Line 203 – “provisionally termed” Lines 209-10 need rewording Line 211- “is T rich”, “structures” Line 240 “are G” Lines 241-2 - “suggest that, like ICEs, SEs target a few selected locations”. Line 284 – “nicks” Line 291 – “mechanism, transposition followed by homologous recombination, rather than through Line 306 – “upon circularization” Line 314 – “or the generation of circular integron gene cassettes”, why “donor sites” Line 332 - “when long” Lines 372-3 – “at the C end” Line 384 – “nicking of one strand of” Line 400 “The location” Line 412 – “of strains are” Line 413 – “integrated” Line 484-5 – “in transposition” Line 459 “Among the types of transposon movement” Line 486-7 – “with fewer gene cassettes” Line 469 – “barely accompanies” not clear Line 472 “of gene cassettes” Line 481 – “was repeatedly”? Lie 482 - delete “step” Line 496 - “an HUH” Line 505 - “numbers” rather than “digits”? Line 514 – replace “strain 04Ya108” with “it” Line 516 “re-classified” Line 530 – “The 19 transconjugants listed ()” Lines 616-7 – “Ap concentrations” Line 632 – “searched for” Reviewer #2: The authors have satisfactorily addressed all my previous comments. A few minor corrections are listed below. Minor corrections: Line 27: "multidrug resistance conjugative plasmid" should have been changed to "conjugative multidrug resistance plasmid". Line 106: "are called" should be "is called". Fig. 1C: The location of the conserved R at the top of Box I appears to be misaligned by two residue positions. After line 180: It would be helpful for readers for S5 Fig B was referred to specifically at the appropriate place. Line 196: "but not" should be "rather than". Line 209: "nucleotide" should be "nucleotides". Line 210: "Sequence" should be "sequence". Line 222: "trshown" should presumably just be "shown". Line 249: "Sequence logos" should be "sequence logo". Line 287: "transconjugant" should be "transconjugants". Line 348: "circular a" should be "a circular". Line 412: "strain" should be "strains". Line 428: "water etc" should just be "water". Line 496: "carry oriT" should be "carry an oriT". Line 498: "identify oriT" should be "identify an oriT". Line 502: "MDR conjugative plasmids" should be "conjugative MDR plasmids". S5 Fig B legend. This legend is inadequate. It should at least say it is a Southern blot and give some insight into the probe used - can refer to S5 Fig A legend where it is shown (but not described). Likewise for the S5 Fig C legend. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 3 |
|
Atypical integrative element with strand-biased circularization activity assists interspecies antimicrobial resistance gene transfer from Vibrio alfacsensis PONE-D-21-18582R3 Dear Dr. Nonaka, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Axel Cloeckaert Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-21-18582R3 Atypical integrative element with strand-biased circularization activity assists interspecies antimicrobial resistance gene transfer from Vibrio alfacsensis Dear Dr. Nonaka: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Axel Cloeckaert Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .